The World's Greatest Sports Coupes: the Petersen's Newest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The World's Greatest Sports Coupes: the Petersen's Newest Exhibit Features 12 Celebrity Curators

Los Angeles, Calif., April 10, 2014 (GLOBE NEWSWIRE) -- -

  • "The World's Greatest Sports Coupes"  exhibit runs April 10 through October 18, 2014 at the Petersen
  • Guest curators include Patrick Dempsey, Francis Ford Coppola, Pink Floyd's Nick Mason and others
  • Exhibit highlights the greatest sports coupes of the past century, ranging from the Jaguar E-Type to the Corvette Stingray and the Acura NSX, plus nine other vehicles
  • Short video pieces will play in the exhibit, featuring each guest curator and their personal relationship with the car that they have chosen
  • Made possible by Jaguar in celebration of the launch of new Jaguar F-TYPE Coupe

Rarely does one genre of car so broadly resonate with people, but sports coupes, with sensuous designs and inspiring capability, generate excitement everywhere they are seen. For its newest exhibit, The World's Greatest Sports Coupes, the Petersen Automotive Museum invited twelve celebrities--ranging from rock 'n roll legends, critically acclaimed film directors, actors and world renown car collectors--to guest curate one sports coupe each. The exhibit, which is now open, showcases some of the most beautiful sports coupes known to man.

The selected sports coupes and their celebrity curators are:  

  • 1948 Jaguar Custom "Black Pearl" chosen by Metallica's James Hetfield
  • 1954 Plymouth Explorer Concept chosen by film director and producer, Francis Ford Coppola
  • 1955 Mercedes-Benz 300 SL Gullwing chosen by world renowned car collector, Bruce Meyer
  • 1961 Aston Martin DB4 Zagato chosen by Jaguar's Director of Design, Ian Callum
  • 1962 Ferrari 250 GTO chosen by Pink Floyd's Nick Mason
  •  1963 Ferrari Berlinetta Lusso chosen by comedian and TV host, Adam Carolla
  • 1963 Chevrolet Corvette Stingray chosen by Top Gear USA hosts: Tanner Foust, Adam Ferrara and Rutledge Wood
  • 1964 Porsche 356SC chosen by actor and race car driver, Patrick Dempsey
  • 1967 Jaguar E-Type chosen by American racer and team owner, Bobby Rahal
  • 1968 Ford GT40 Mark III chosen by Chief Creative Officer of Pixar and Disney, John Lasseter
  •  1974 Iso Grifo chosen by AC/DC's Brian Johnson
  • 1991 Acura NSX chosen by Motor Trend Magazine's Angus MacKenzie

"As we're about to launch the new F-TYPE Coupe, we are proud to be involved with an exhibit that celebrates game-changing coupes," said Jeff Curry, Brand Vice President, Jaguar.  "This new approach of curating diverse opinions from a range of automotive enthusiasts brings a real energy to the exhibit and fits the Petersen perfectly. One of the great things about being a car lover is that we can all have our own point of view on what makes a sports coupe deserving to be part of the 'World's Greatest.'"

With such a broad history, narrowing the greatest sports coupes ever down to twelve choices was no easy task. The exhibit will also feature photography by Scott Williamson, which will highlight important sports coupes that were not included by any of the celebrity curators but deserve recognition.

"Sports coupes are the reason most of us fell in love with the automobile in the first place," said executive director of the Petersen, Terry Karges. "These vehicles represent the pinnacle of art, design, engineering and performance and have been built all over the world. Choosing a dozen sports coupes to represent the finest of the breed was no easy task, which is why we invited the world's most prominent car collectors to guest curate this exhibit. We're honored to work with all twelve of these individuals as well as with Jaguar, a company that has well earned its legacy building beautiful vehicles."

We want to know: what car do you think is the great sports coupe of all time? Tell us on our social channels: Facebook , Twitter and Instagram using hashtags #ThePetersen and #GreatestCoupes.

The Petersen Automotive Museum Foundation is a non-profit 501(c)(3) charity.  The Museum is located at 6060 Wilshire Boulevard (at Fairfax) in Los Angeles, California 90036.  Admission prices are $15 for general admission adults, $10 for seniors, $10 for students with ID, $5 for children ages 3 to 12. Museum members, active military with ID and children under three are admitted free. Vault tours are available for an additional $25, and are offered on a first-come, first-served basis. Parking is free for the first 30 minutes and $2.00 each additional 30 minutes. One hour validation with purchase of $10 or more in the Museum Store or Johnny Rockets located in the museum lobby.  Museum hours are Tuesday through Sunday from 10am to 6pm. For general Museum information, call 323/930-CARS or visit the Museum's Web site at: www.petersen.org .  Remember to like us on Facebook , and follow us on Twitter and Instagram .

###

Laura Conrad|Kahn Media 818-881-5246|

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading